Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1042.5500 -1.70 (-0.16%)
NSE Apr 09, 2026 15:42 PM
Volume: 43,963
 

logo
Alivus Life Sciences Ltd.
16 Jul 2024
1042.55
-0.16%
buy
by Hem Securities
Target: 987
Hem Securities
 
Alivus Life Sciences Ltd. is trading above all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Market closes lower as Middle East tensions weaken ceasefire optimism
Trendlyne Marketwatch | 09 Apr 2026, 03:57PM
After the drop, are stock market valuations finally reasonable?
The Baseline | 09 Apr 2026, 03:18PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021